Navigation Links
Watson Names Lisa DeFrancesco Vice President, Global Investor Relations
Date:5/4/2012

PARSIPPANY, N.J., May 4, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that Lisa M. DeFrancesco has been promoted to the position of Vice President, Global Investor Relations, effective immediately.  In this position, Ms. DeFrancesco reports to Charles Mayr, Chief Communications Officer – Global.  She succeeds Patricia Eisenhaur, who is leaving Watson on June 1, 2012.

In this position, Ms. DeFrancesco is responsible for Watson's proactive global investor relations programs and serves as the principle spokesperson and point of contact with the analyst and investment community. She also provides current relevant business, competitor and financial community insight to senior management.

Ms. DeFrancesco joined Watson in 2009 as Manager, Investor Relations.  She was promoted to Director, Investor Relations in 2010.  Ms. DeFrancesco brought more than 12 years of experience to Watson, having served in various finance and investor relations roles at such companies as Virgin Mobile USA, Realogy, Cendant and Horizon Blue Cross/Blue Shield/NJ.  She began her career on Wall Street as a sell-side analyst at Ladenburg Thalmann & Co.  Ms. DeFrancesco has a BS degree in Business Administration from Seton Hall University.

About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. The Company is also developing biosimilar products in Women's Health and Oncology.  Additionally, Watson distributes generic and branded pharmaceuticals through its Anda, Inc. distribution business. Watson has operations in many of the world's established a
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings
3. Taconic IPAs Annette Watson to present at PCPCC meeting
4. Watson Launches Generic FORTAMET(R)
5. Auxilium Pharmaceuticals, Inc. and FCB I LLC Receive Paragraph IV Certification Notice from Watson Laboratories, Inc. for Testim®
6. Watson Confirms Favorable District Court Ruling in Generic Sanctura XR® Patent Suit
7. Watson Partners With March of Dimes to Help Fight Preterm Birth
8. Watson Confirms NIASPAN(R) Patent Challenge
9. Watson Confirms BYSTOLIC(R) Patent Challenge
10. Watson Launches Generic PROMETRIUM(R)
11. Watson to Present at the Barclays Capital 2012 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... LONDON , May 6, 2015 ... HIV maintenance therapy with dolutegravir and rilpivirine ... start of a Phase III clinical trial programme ... (Tivicay®) and rilpivirine (Edurant® [1] ) as maintenance ... III programme comprises two replicate studies evaluating 48 ...
(Date:5/6/2015)... , May 6, 2015   Wilson Therapeutics ... CEO Jonas Hansson has been invited to ... the annual BioEquity Conference, this year to be held ... May 19 th . About WTX101 ... is currently in Phase 2 testing for Wilson Disease. ...
(Date:5/6/2015)... , May 6, 2015 ... join the Wellcome Trust and the Bill & ... Kymab, a leading monoclonal antibody biopharmaceutical ... an additional US$50 million to complete a US$90 ... being invested by Woodford Patient Capital Trust plc ...
Breaking Medicine Technology:ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 2ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 3ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 4ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 5ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 6ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 7ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 8ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 9ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 10Wilson Therapeutics To Present As A "Next Wave" Company During BioEquity 2015 Conference In Vienna On May 19th 2Kymab Secures US$90 Million Funding 2Kymab Secures US$90 Million Funding 3Kymab Secures US$90 Million Funding 4
... 2011  Allocate Software plc, the leading provider of workforce ... its presence in the US with the announcement that ... scheduling solution, to create and manage schedules for its ... a leading provider of a diverse range of imaging ...
... Endo Pharmaceuticals (Nasdaq: ENDP ) today announced that ... present a corporate overview at the Bank of America Merrill ... at 7:30 a.m. ET.  The conference will be held at ... A live webcast and audio archive of the presentation will ...
Cached Medicine Technology:Allocate Software's Healthroster Selected by Austin Radiological Association 2
(Date:5/6/2015)... Launch Corporation, LLC. is pleased to announce that Launch Trampoline ... Tanguay Avenue. Owned and operated by Rick Arnold and Phil ... New England. , “We are extremely excited for Rick and ... and CEO of Launch. “They have established great roots in ... continue to establish that positive growth in the greater Nashua ...
(Date:5/6/2015)... May 06, 2015 The SGNY Group ... York City, announced today that it was named a ... a presentation video produced on behalf of Intarcia Therapeutics. ... category of motion graphics. , The competition sponsored by ... over 6000 entries from 22 countries. The competition ...
(Date:5/5/2015)... 06, 2015 It’s not your usual Veterans ... their classic cars and motorcycles to the 3rd Annual “Crusin ... 8 p.m. at the Lincoln VA Clinic, 600 S. 70th ... to check out each other’s rides, but also to talk ... and services. , Staff from the VA Nebraska-Western Iowa ...
(Date:5/5/2015)... Private equity consultant and international research ... that its dental stem cell biobank project, Provia ... April, 2015 –and posted yet another exciting record. This ... and represents a significant 54% increase over last April ... is conducted via the Store-A-Tooth brand. The company has ...
(Date:5/5/2015)... “Given that Hispanics are one in six people ... are a major step in the arsenal of facts documenting ... past 30 years, data have accumulated that the health of ... the urgency and the need to create new models of ... all,” said Jane L. Delgado, PhD, MS, President and CEO ...
Breaking Medicine News(10 mins):Health News:Jump Up and Celebrate: Launch Trampoline Park Opens in Nashua, NH 2Health News:The SGNY Group Wins Platinum Hermes Creative Award 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 3Health News:“Its about time,” Declares the National Alliance for Hispanic Health on First CDC Study of Hispanic Health 2
... the brain could play a key role in regulating ... plaques implicated in the development of Alzheimer,s disease, according ... A group led by Domenico Pratico, professor of pharmacology ... of the protein, called 12/15-Lipoxygenase, in the brain three ...
... News) -- Researchers who found the earliest known ... the evolution of complex reproductive behavior in early dinosaurs. ... million years older than previously known nesting sites. It ... Massospondylus , a relative of the giant, long-necked sauropods ...
... (HealthDay News) -- Researchers who identified a protein that ... eventually lead to new treatments for the neurodegenerative disease. ... in neurons in the striatum, the part of the ... Parkinson,s disease in mice, the researchers found that RGS4 ...
... a genetic outlier, which has prevented scientists from discovering the ... Health and Yale University School of Medicine have devised a ... , the major cause of human malaria. This new approach ... and opens the door to further genetic discovery for the ...
... Calif. (January 25, 2012) Gardasil, the human papillomavirus ... adolescents and young adults, does not trigger autoimmune conditions ... multiple sclerosis after vaccination in young women, according to ... Medicine . Kaiser Permanente researchers used electronic health ...
... , WEDNESDAY, Jan. 25 (HealthDay News) -- Learning to ... with autism make plans and complete complex daily tasks, ... that people with autism can live independent, flexible lives, ... Durham University in England. The researchers compared how ...
Cached Medicine News:Health News:Protein in the brain could be a key target in controlling Alzheimer's 2Health News:Oldest Known Dinosaur Nesting Site Found 2Health News:Protein That Controls Movement Does the Opposite in Parkinson's 2Health News:Researchers discover method to unravel malaria's genetic secrets 2Health News:Kaiser Permanente study finds Gardasil does not trigger autoimmune conditions after vaccination 2Health News:'Inner Dialogue' Might Aid People With Autism 2
... The AlphaPette Pipettor is the ... beyond. Offers accuracy, comfort, and reliability. ... digital volume readout sub-micrometer. Easy interchangeable ... or tiny hands. Adjustable rapid pipet ...
... Pipetman Ultra is a fully adjustable, air-displacement ... It is the latest member of the ... characteristics: robustness, accuracy, and precision. We also ... feedback from our customers. Eight models cover ...
... Thermo Labsystems was designed specifically to combine ... such as the new fast dial system ... help to define this as a new ... interchangeable handle plate offers a custom fit ...
... In the specialty areas ... or intensive care work, it ... in your practice. Alokas motorized ... Doppler and Tissue Harmonic Echo ...
Medicine Products: